Company intelligence / Profile preview

Vara

Berlin, Berlin, Germany

Ownership: Private
Development stage: Other

Overview

Vara's AI-powered platform for breast cancer screening has been deployed in multiple countries, validated in large-scale studies (including the world's largest prospective AI mammography study), showing improvement in detection rate, workload reduction, and workflow efficiency for radiology departments. Over 80,000 screenings monthly use the platform in Germany, with expansion ongoing in other regions.

Therapeutic areas: Oncology
Modalities: DeviceAI softwareMedical device
Industry: Medical Imaging

Partnerships

University of LübeckGerman Breast Cancer Screening ProgramMamotest (Mexico)MITERA Hospital (Greece)

Beyond the preview

Go deeper on Vara.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vara.

Explore the full profile